AstraZeneca Initiates 9 IP Suits Over Crestor ANDAs
AstraZeneca Pharmaceuticals LP has launched separate patent infringement actions against nine rival drugmakers — including Apotex Corp., Mylan Pharmaceuticals Inc. and Teva Pharmaceuticals USA Inc. — seeking to block their attempts...To view the full article, register now.
Already a subscriber? Click here to view full article